Bittencourt Aline Gomes, Burke Patrick Rademaker, Jardim Isabela de Souza, Brito Rubens de, Tsuji Robinson Koji, Fonseca Anna Carolina de Oliveira, Bento Ricardo Ferreira
Department of Otolaryngology, Universidade de São Paulo, São Paulo, São Paulo, Brazil.
Int Arch Otorhinolaryngol. 2014 Jul;18(3):303-10. doi: 10.1055/s-0033-1363463. Epub 2014 Apr 9.
Introduction The complaints associated with the use of conventional amplifying hearing aids prompted research at several centers worldwide that ultimately led to the development of implantable devices for aural rehabilitation. Objectives To review the history, indications, and surgical aspects of the implantable middle ear hearing devices. Data Synthesis Implantable hearing aids, such as the Vibrant Soundbridge system (Med-El Corporation, Innsbruck, Austria), the Maxum system (Ototronix LLC, Houston, Texas, United States), the fourth-generation of Carina prosthesis (Otologics LLC, Boulder, Colorado, United States), and the Esteem device (Envoy Medical Corporation - Minnesota, United States), have their own peculiarities on candidacy and surgical procedure. Conclusion Implantable hearing aids, which are currently in the early stages of development, will unquestionably be the major drivers of advancement in otologic practice in the 21st century, improving the quality of life of an increasingly aged population, which will consequently require increased levels of hearing support.
引言 使用传统放大助听器引发的问题促使全球多个中心开展研究,最终促成了用于听力康复的可植入设备的研发。目的 回顾可植入中耳听力设备的历史、适应证及手术相关情况。资料综合 可植入助听器,如振动声桥系统(奥地利因斯布鲁克美迪普公司)、Maxum系统(美国得克萨斯州休斯敦奥拓特尼克斯有限责任公司)、第四代卡瑞娜假体(美国科罗拉多州博尔德奥拓逻辑斯有限责任公司)以及Esteem设备(美国明尼苏达州Envoy医疗公司),在适应证及手术操作方面各有特点。结论 目前处于研发初期的可植入助听器无疑将成为21世纪耳科实践进步的主要推动力,改善日益老龄化人群的生活质量,而这将相应地需要更高水平的听力支持。